All the news Showing 10 of 442 articles from: TherapiesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources FDA approves first treatment for all genotypes of hepatitis C in pediatric patients Food & Drug Administration / 02 May 2019 Penn team eradicates Hepatitis C in patients after heart transplants from infected donors Manual Items / 26 February 2019 Hundreds of Britons who buy KIDNEYS on the black market from overseas traffickers charging £30,000 in a bid to avoid NHS waiting lists are coming back with deadly diseases such as HIV and hepatitis Daily Mail / 21 January 2019 New treatment could see NZ eradicate Hepatitis C in next 20 years Newshub / 17 December 2018 The Medicines Patent Pool signs licence with AbbVie to expand access to key hepatitis C treatment, glecaprevir/pibrentasvir Medicines Patent Pool / 12 November 2018 Inovio and Korean Partner Dose 1st Subject In Trial to Develop World’s First Vaccine to Prevent Hepatitis C Infection Inovio press release / 06 September 2018 New hepatitis C drugs mean diseased organs can be used for transplants Philly.com / 15 August 2018 Ascletis Receives NDA Approval from China FDA for Ganovo Ascletis press release / 13 June 2018 China Drug Administration Approves Epclusa® (Sofosbuvir/Velpatasvir), Gilead’s Pan-Genotypic Treatment for Chronic Hepatitis C Virus Infection Gilead press release / 30 May 2018 Two Hepatitis C Virus Infection Treatments to Be Discontinued MPR / 29 May 2018 ← First12345...45Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Transmission and prevention Diagnosis and monitoring Disease course and symptoms HCV and coinfections Living with HCV Treatment issues Side effects Therapies Liver transplants Hepatitis D Hepatitis E NAFLD Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds